Business of Cannabis Europe
MGC Pharmaceuticals Says It May Need A Further Capital Raise As Losses Grow
MGC Pharmaceuticals (MXC) has reported its ‘its strongest half-year result to date’ seeing sales more than triple year-on-year, helping lift its stock price out of an all-time low.
Ben Stevens
March 3, 2022
